Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M.
D000328:Adult; D028226:Amyloidosis, Familial / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D000740:Anemia / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D001794:Blood Pressure; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D011228:Prealbumin / Q000235:genetics*; D011994:Recombinant Proteins; D013997:Time Factors; D016896:Treatment Outcome
D006454:Hemoglobins; D011228:Prealbumin; D011994:Recombinant Proteins; D004921:Erythropoietin